Yiming Xu Selected Research

Adenosine Kinase

1/2021	Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation.
1/2019	Endothelial adenosine kinase deficiency ameliorates diet-induced insulin resistance.
12/2018	Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE-/- (Apolipoprotein E Deficient) Mice.
10/2017	Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation.
11/2016	Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiming Xu Research Topics

Disease

18	Neoplasms (Cancer) 05/2022 - 08/2002
11	Inflammation (Inflammations) 02/2022 - 11/2011
6	Neoplasm Metastasis (Metastasis) 02/2022 - 11/2019
5	Wounds and Injuries (Trauma) 01/2022 - 01/2015
5	Hypoxia (Hypoxemia) 12/2020 - 01/2017
4	Atherosclerosis 11/2022 - 10/2017
4	Stroke (Strokes) 02/2022 - 01/2016
4	Infections 01/2022 - 01/2017
4	Hemorrhage 10/2020 - 06/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2017 - 04/2011
3	Osteoarthritis 06/2022 - 08/2021
3	Adenocarcinoma of Lung 01/2022 - 01/2019
3	Neointima 01/2022 - 01/2020
3	Vascular Diseases (Vascular Disease) 10/2020 - 01/2018
3	Thrombosis (Thrombus) 06/2015 - 04/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2015
2	Ischemia 01/2022 - 09/2012
2	Brain Injuries (Brain Injury) 01/2022 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2021
2	Vascular System Injuries 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2019
2	Vascular Remodeling 01/2020 - 08/2014
2	Insulin Resistance 01/2019 - 01/2014
2	Atherosclerotic Plaque (Atheroma) 12/2018 - 04/2012
2	Fibrosis (Cirrhosis) 07/2017 - 01/2016
2	Reperfusion Injury 01/2016 - 09/2012
1	Gram-Negative Bacterial Infections 10/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 09/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2022
1	Nasopharyngeal Carcinoma 05/2022
1	Congenital Abnormalities (Deformity) 04/2022
1	Oral Lichen Planus 04/2022
1	Rheumatoid Arthritis 02/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Osteomyelitis 01/2022
1	Skin Ulcer 01/2022
1	Spontaneous Fractures (Pathological Fracture) 01/2022
1	Precocious Puberty 01/2022
1	Hemophilia A (Haemophilia) 01/2022

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 10/2022 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
5	EnzymesIBA 11/2022 - 04/2013
5	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2019
5	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2019
5	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2017
5	Adenosine KinaseIBA 01/2021 - 11/2016
4	InflammasomesIBA 08/2022 - 01/2019
4	Peptides (Polypeptides)IBA 05/2022 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2022 - 06/2015
4	Retinaldehyde (Retinal)IBA 01/2021 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 10/2020
3	6-methyladenineIBA 02/2022 - 01/2022
3	Oxygen (Dioxygen)IBA 12/2020 - 11/2005
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2019 - 09/2012
3	Scavenger Receptors (Scavenger Receptor)IBA 12/2014 - 11/2011
2	Apolipoproteins E (ApoE)IBA 11/2022 - 12/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 06/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2002
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 01/2017
2	CateninsIBA 01/2021 - 06/2017
2	MatrinesIBA 01/2020 - 01/2019
2	tanshinoneIBA 01/2020 - 04/2012
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2014
2	oxidized low density lipoproteinIBA 12/2018 - 04/2011
2	CytokinesIBA 01/2017 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2013
2	Therapeutic UsesIBA 01/2017 - 05/2010
2	Small Interfering RNA (siRNA)IBA 06/2015 - 01/2015
2	LipidsIBA 01/2009 - 08/2002
1	PFK158IBA 11/2022
1	nangibotideIBA 06/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2022
1	GraphiteIBA 05/2022
1	lipoarabinomannan (LAM)IBA 02/2022
1	toddalolactoneIBA 02/2022
1	MethyltransferasesIBA 02/2022
1	N-methyladenosineIBA 01/2022
1	Fluconazole (Zonal)FDA LinkGeneric 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Antifungal AgentsIBA 01/2022
1	paeonolIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2022
1	MacrolidesIBA 01/2022

Therapy/Procedure

16	Therapeutics 09/2022 - 04/2013
3	Drug Therapy (Chemotherapy) 05/2022 - 11/2019
2	Ligation 01/2022 - 01/2020
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2015 - 01/2011
1	Quantum Dots (Quantum Dot) 05/2022
1	Prostheses and Implants (Prosthesis) 04/2022
1	Topical Administration 04/2022
1	Surgical Amputation (Amputations) 01/2022